Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery

被引:1
作者
Qing, Xuemei [1 ,2 ]
He, Lele [1 ,4 ]
Ma, Ying [3 ,5 ]
Zhang, Yong [1 ,3 ]
Zheng, Wenxin [6 ]
机构
[1] Southwest Med Univ, Dept Obstet & Gynecol, Luzhou 646000, Sichuan, Peoples R China
[2] Qingbaijiang Dist Peoples Hosp, Dept Obstet & Gynecol, Chengdu 610300, Sichuan, Peoples R China
[3] Mianyang Cent Hosp, Dept Obstet & Gynecol, Mianyang 621000, Sichuan, Peoples R China
[4] Chongzhou Maternal & Child Hlth Care Hosp, Dept Obstet & Gynecol, Chengdu 611200, Sichuan, Peoples R China
[5] Chengdu Med Coll, Dept Obstet & Gynecol, Chengdu 610500, Sichuan, Peoples R China
[6] Univ Texas Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dept Obstet & Gynecol, Dept Pathol, Dallas, TX 75390 USA
关键词
Endometriosis; Conservative surgery; GnRH-a; Pregnancy rate; STAGE-III-IV; OVARIAN RESPONSIVENESS; LAPAROSCOPIC SURGERY; EXPECTANT MANAGEMENT; THERAPY; RECURRENCE; INFERTILITY; DIENOGEST; DISEASE; IMPACT;
D O I
10.1186/s12884-024-06430-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Endometriosis frequently results in pain and infertility. While conservative surgery offers some relief, it often falls short of ensuring satisfactory pregnancy outcomes. Adjuvant GnRH-a is administered post-surgery to mitigate recurrence; however, its impact on pregnancy outcomes remains debated. This study endeavors to assess the efficacy of adjuvant GnRH-a in enhancing pregnancy outcomes post-conservative surgery in endometriosis patients. Methods Databases including PubMed, Embase, the Cochrane Library, Medline (Ovid), Web of Science, and Scopus were rigorously searched up to 02 August 2023, without linguistic constraints. Identified articles were screened using strict inclusion and exclusion criteria. Evaluated outcomes encompassed pregnancy rate, live birth rate, miscarriage rate, ectopic pregnancy rate, multiple pregnancy rate, mean postoperative pregnancy interval, recurrence rate, and adverse reaction rate. The Cochrane risk of bias tool and the Jadad score evaluated the included studies' quality. Subgroup and sensitivity analysis were implemented to analyze the pooled results. A meta-analysis model expressed results as standardized mean difference (SMD) and Risk ratio (RR). Results A total of 17 studies about 2485 patients were assimilated. Meta-analysis revealed that post-surgery, the GnRH-a cohort experienced a marginally elevated pregnancy rate (RR = 1.20, 95% CI = 1.02-1.41; P = 0.03) and a reduced mean time to conceive (RR = -1.17, 95% CI = -1.70- -0.64; P < 0.0001). Contrarily, other evaluated outcomes did not exhibit notable statistical differences. Conclusions Incorporating adjuvant GnRH-a following conservative surgery may be deemed beneficial for women with endometriosis, especially before Assisted Reproductive Technology (ART). Nonetheless, owing to pronounced heterogeneity, subsequent research is warranted to substantiate these potential advantages conclusively.
引用
收藏
页数:16
相关论文
共 69 条
  • [41] A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis
    Loverro, Giuseppe
    Carriero, Carmine
    Rossi, A. Cristina
    Putignano, Giuseppe
    Nicolardi, Vittorio
    Selvaggi, Luigi
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 136 (02) : 194 - 198
  • [42] The effect of endometriosis on live birth rate and other reproductive outcomes in ART cycles: a cohort study
    Muteshi, Charles M.
    Ohuma, Eric O.
    Child, Tim
    Becker, Christian M.
    [J]. HUMAN REPRODUCTION OPEN, 2018, 2018 (04) : 1 - 7
  • [43] Endometriosis: ancient disease, ancient treatments
    Nezhat, Camran
    Nezhat, Farr
    Nezhat, Ceana
    [J]. FERTILITY AND STERILITY, 2012, 98 (06) : S1 - S62
  • [44] Ovarian responsiveness in assisted reproductive technology after CO2 fiber laser vaporization for endometrioma treatment: preliminary data
    Ottolina, Jessica
    Ferrari, Stefano
    Bartiromo, Ludovica
    Bonavina, Giulia
    Salmeri, Noemi
    Schimberni, Matteo
    Makieva, Sofia
    Tandoi, Iacopo
    Papaleo, Enrico
    Vigano, Paola
    Candiani, Massimo
    [J]. MINERVA ENDOCRINOLOGICA, 2020, 45 (04) : 288 - 294
  • [45] GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles
    Pabuccu, Recai
    Onalan, Gogsen
    Kaya, Cemil
    [J]. FERTILITY AND STERILITY, 2007, 88 (04) : 832 - 839
  • [46] Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1136/bmj.n160, 10.1016/j.ijsu.2021.105906]
  • [47] Pain and ovarian endometrioma recurrence after laparoscopic treatment of endometriosis: a long-term prospective study
    Porpora, Maria Grazia
    Pallante, Debora
    Ferro, Annamaria
    Crisafi, Brenda
    Bellati, Filippo
    Panici, Pierluigi Benedetti
    [J]. FERTILITY AND STERILITY, 2010, 93 (03) : 716 - 721
  • [48] Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis
    Rickes, D
    Nickel, I
    Kropf, S
    Kleinstein, J
    [J]. FERTILITY AND STERILITY, 2002, 78 (04) : 757 - 762
  • [49] Endometriosis and IVF: are agonists really better? Analysis of 1180 cycles with the propensity score matching
    Rodriguez-Purata, Jorge
    Coroleu, Buenaventura
    Tur, Rosa
    Carrasco, Beatriz
    Rodriguez, Ignacio
    Nolasco Barni, Pedro
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (09) : 859 - 862
  • [50] Effect of GnRH agonist before IVF on outcomes in infertile endometriosis patients: a randomized controlled trial
    Rodriguez-Tarrega, Elisabet
    Monzo, Ana M.
    Quiroga, Ramiro
    Polo-Sanchez, Patrocinio
    Fernandez-Colom, Pedro
    Monterde-Estrada, Mercedes
    Novella-Maestre, Edurne
    Pellicer, Antonio
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2020, 41 (04) : 653 - 662